drugset
drugset / Trial / NCT02837692

A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults

NCT02837692 ↗

Phase 1 Completed 140 enrolled Janssen Research & Development, LLC
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in elderly non-Asian adults compared with weight- and gender-matched young healthy non-Asian adults and to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in healthy Japanese adults.

Timeline

Start
2016-06-08
Primary completion
2017-09-07
Completion
2017-09-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Seltorexant Small molecule 10 mg Oral
Subject Seltorexant Small molecule 20 mg Oral
Subject Seltorexant Small molecule 40 mg Oral
Subject Seltorexant Small molecule 60 mg Oral
Subject Seltorexant Small molecule 80 mg Oral

Indications

No indication recorded.